PapersPMID:35088071
Acanthopanax senticosus total flavonoids alleviate lipopolysaccharide-induced intestinal inflammation and modulate the gut microbiota in mice.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- animal · not in humans · 7 days
- Dose studied, every finding
- 200, 400 or 800 mg/kg once daily by intragastric gavage for 7 days after the LPS injection
What moved
How to read these marks →“Compared with the LPS model group, ASTF significantly reduced the contents of IL-1β, IL-6, PGE2 and TNF-α in each dosage group (P<0.001), and except for the content of IL-1β, all of these effects were dose-dependent.”
- Population
- Male Kunming mice with intestinal inflammation induced by intraperitoneal LPS 10 mg/kg; serum TNF-α by ELISA after 7 days of treatment; all three ASTF dose groups (200, 400, 800 mg/kg) against the LPS model group
- Decreases interleukin-6 concentration
very limited
- Population
- Male Kunming mice with intestinal inflammation induced by intraperitoneal LPS 10 mg/kg; serum IL-6 by ELISA after 7 days of treatment; all three ASTF dose groups (200, 400, 800 mg/kg) against the LPS model group
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- Male Yunnan Kunming mice, 5 weeks old, with LPS-induced intestinal inflammation (10 mg/kg LPS intraperitoneally)
- Participants
- 50
- Comparator
- an active treatment / placebo
- Duration
- 7 days
- Endpoints measured
- 78